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We have Isolated storage cytosomes from brain tissue of patients with infantlIe neuronal ceroid-hpofuscinosls. The purltied storage bodies were 
subjected to compositional analysis which revealed a high content of protems, accounting for 43% of dry weight. Saposms A and D. also known 
as sphingohpid acnvator protems (SAPS). were shown to constitute a major portIon of the accumulated protem usmg gel electrophoresis and 
sequence analysis. This is the first time that saposms have been found to be stored in any form of neuronal cerold-hpofuscmosls. 
InfantlIe neuronal cerold-hpofuscinosis: Saposin; Lysosomal storage disease: Batten’s disease 
1. INTRODUCTION 
The neuronal ceroid-lipofuscinoses (NCL) [I] collec- 
tively constitute the most common group of inherited 
lysosomal storage disorders of the nervous system, with 
an estimated incidence of 1: 12,500 births [2]. Their clin- 
ical manifestations include severe progressive psycho- 
motor deterioration and blindness in the childhood 
forms [3,4]. Granular autofluorescent sudanophilic 
storage bodies. which are relatively resistant to lipid 
solvents in histological sections, accumulate in neurons. 
and in many other cell types albeit to a lesser extent. The 
ultrastructure of these electron-dense storage cytosomes 
varies, being finely granular in the infantile type and 
displaying a curvilinear or fingerprint pattern in the late 
infantile and juvenile forms of NCL [5]. Direct protein 
sequencing has shown that subunit c of mitochondrial 
ATP synthase is stored in an ovine [6] and other animal 
models of NCL, as well as in the late infantile and 
juvenile types of human NCL, but not in the infantile 
form [7]. The genes for the infantile [S] and juvenile [9] 
types have been mapped to chromosomes 1 and 16, 
respectively. 
Saposins, also called sphingolipid activator proteins 
(SAPS), are small heat-stable glycoproteins needed for 
the hydrolysis of sphingolipids in lysosomes [IO,1 11. 
They are derived from a common precursor. pro- 
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saposin, a 70 kDa glycoprotein proteolytically proc- 
essed to saposins A, B. C and D [ 12,131. All saposins are 
structurally similar to one another, having six conserved 
cysteines, one common glycosylation site, and prolines 
in similar positions [1 11. In spite of these structural sim- 
ilarities. the individual saposins differ in their specificity 
for, and mode of activation of, individual sphingolipid 
hydrolases [ 141. 
Accumulation of saposins has recently been found in 
certain sphingolipid storage disorders [ 11.1.5,16]. We 
now report the occurrence saposins A and D, as integral 
constituents of the storage cytosomes in infantile neu- 
ronal ceroid-lipofuscinosis (INCL). 
2. MATERIALS AND METHODS 
Brain tissue specimens obtamed at routine autopsies S-24 h post- 
mortem and kept frozen at -70°C from three male and one female 
JNCL patients (ages 11-14 years), one male patlent with Juvenile 
neuronal ceroid-hpofuscinosls (JNCL) (age 34 years), and one neurol- 
ogically normal male mdlvidual (37 years of age) were used for the 
biochemical analyses The diagnoses of all patients had been verified 
hlstologically and by electron mIcroscopy [5] 
2.2 IJolurlon of ilw srorugr mater& 
The storage bodies were Isolated from the brams of JNCL and 
JNCL patients essentially following the method of Palmer et al. [17]. 
The tissue was thawed and homogenized in Milli-Q water (1 g/10 ml), 
then the homogenate was filtered through glass wool and the filtrate 
sonicated for 1 min and centrifuged at I .500 x g for 20 min. The 
resultant pellet was suspended m Milli-Q water. dlvlded mto ahquots, 
loaded onto 20-35s (w/v) CsCl gradlents and centrifuged at 
20.000 x g for 15 h in a swing-out rotor The storage material, Identi- 
fied by its characteristic yellow-browmsh color. was collected. diluted 
with Mllli-Q water. and pelleted at 1.500 x g for 20 mm. All operations 
were carried out at 4°C. The punty of Isolated storage bodies was 
monitored by electron tmcroscopy. Control bram material was sub- 
jected to an identical procedure. Sheep hver storage bodies were puri- 
fied from sheep affected with cerold-hpofuscmosls. as described [ 171. 
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2.3. Morphologrcal studus 
Tissues fixed in 4% phosphate-buffered formaldehyde were embed- 
ded in paraffin and sectioned at 6 pm. Sections were stained for light 
microscopy using hematowylineosm or Luxol fast blue, Cresyl violet 
or periodic acid. Schiff or Sudan black B. Unstained sections were 
viewed with ultraviolet light to detect autofluorescent granules. Small 
pieces of tissue or isolated storage bodies were fixed in 2% phosphate- 
buffered glutaraldehyde and embedded in Epon resin for transmission 
electron microscopy. Double-stained thin sections were viewed in a 
JEOL-JEM 1200 EX electron microscope at 60 V accelerating voltage 
2.4. Analysrs of the compou~t~o~~ of the storage cytosomes 
Isolated INCL brain storage cytosomes were suspended in Mini-Q 
water, aliquots dried under vacuum, and then at 60°C until their 
weights were constant. The weighed storage bodies were then either 
dissolved in 1% (w/v) lithium dodecyl sulphate (LDS) for protein 
analyses, or extracted with chloroform:methanol(2:1) for lipid analy- 
ses. The amount of protein in storage cytosomes was determmed 
according to Markwell et al. [18]. except that sodium dodecyl sulphate 
(SDS) was replaced with LDS. This method was tested for its compat- 
ibility with LDS using bovine serum albumin and P-lactoglobulin as 
standards. p-Lactoglobulin was used as the quantitative standard in 
subsequent analyses. Values determined for samples from individual 
patients were within 13% of the mean. 
Lipids from storage bodies were extracted with chloro- 
form:methanol (2:l) overnight at room temperature, 0.2 vol. of Milh- 
Q water added, and the phases separated by centrifugation at 2,000 x g 
for 10 min. The lipid-containing lower phase was weighed after careful 
drying at 60°C. 
2.5. Polyacrylarnide gel elec~rophoresrs (PAGE) and Western blot 
analysis 
The protein components m the stored material were analyzed on 
PAGE. Both 15% Laemmli [19] and 16.5% glycerol-containing 
Schlgger [20] gels were used. LDS, rather than SDS, was used as a 
detergent in sample buffers. and in Schagger gels The proteins on gels 
were stained either with Coomassie brilliant blue R or with a double 
silver staining method that visualizes proteohpids [21]. 
Western blotting was performed according to Towbin et al. [22]. 
except that the Immun-Blot Alkaline Phosphatase Assay Kit (Bto-Rad 
Laboratories, Richmont. CA) was used to visualize the immunoreac- 
tive proteins. GFAP antiserum was purchased from DAK0 (Copen- 
hagen, Denmark). Antibodies were raised m rabbits against subunit 
c purified from liver storage bodies of sheep affected with NCL. The 
antigen was dissolved into the RIBI adJuvant system (RIB1 Immuno- 
them Research Inc.. Hamilton, MT), and 500 pg inJected 4 times at 
monthly intervals according to the manufacturer’s instructions. 
2.6. Protein sequence analysis 
All amino acid sequence analyses were performed with a fully auto- 
mated ABI 477A/120A protemlpeptide sequencer usmg Edman degra- 
dation followed by on-line analysis of released phenyl thiohydantom 
ammo acid derivatives. Proteins were electroblotted onto polyvi- 
nylidene difluoride (Immobilon P; Milhpore, Bedford, MA) mem- 
branes after PAGE. The blots were briefly stained with 0.2% (w/v) 
Coomassie brilliant blue R in 40% (v/v) methanol. 0.5% (v/v) acetic 
acid, and destained with 50% (v/v) methanol m water. After staining, 
the desired bands were cut out and sequenced as described [23]. Se- 
quence analysis was also performed directly from purified storage 
bodies suspended in Mtlli-Q water by applying them to a Polybrene- 
containing (Fluka Chemte AC. Buchs, Switzerland) trifluoroacetic 
acid-treated glass-fibre filter. 
3. RESULTS 
3.1. Purity and ultrastructure of storage bodies 
The purified storage material from INCL brain tissue 
was composed almost entirely of conglomerates of 
Fig. 1 Purified storage material, isolated from brain tissue of an INCL 
patient. showmg conglomerates of spherical electron-dense cytosomes 
with a granular internal structure. Electron micrograph: bar = 1 pm. 
spherical electron dense cytosomes with a finely granu- 
lar ultrastructure (Fig. 1). corresponding to characteris- 
tic cytoplasmic storage bodies, as seen in intact tissues 
of INCL patients [24,25]. Occasional mitochondria con- 
stituted the only detectable impurity. An identical isola- 
tion procedure applied to control brain tissue did not 
yield any material. 
3.2. Composition of the storage cytosomes 
Two to four preparations were used to measure the 
amount of protein in the storage material from each of 
four patients. Proteins accounted for 43% on average of 
storage body dry weight. Lipids were measured from 
two patients and accounted for 35% on average of stor- 
age body dry weight. Silver staining of the lipid extract 
after PAGE showed that there were no proteins in this 
fraction. 
3.3. Proteins in the storage material 
Direct sequencing of the INCL storage material of 
three patients revealed the presence of two major pro- 
teins in the storage cytosomes, in approximately 
equimolar amounts. The sequences of residues 1-25 
were determined. These sequences were also present in 
bands excised from blots, sometimes in different 
amounts (see below) which allowed the construction of 
probable fragments of individual sequences. The data 
were then untangled into two clear sequences by com- 
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SLPCDICKDVVTAAGDMLKDN*ATEE Saposin A 
XXP -DI-KDVVTAAGDMLKD - ATEE Sequence from 
XX-EV -KKLVGYLDRNLEK- STKQE storage bodies 
DGGFCEVCKKLVGYLDRNLEKN*STKQE Saposin D 
Fig. 2, N-Termmal ammo actd sequences obtamed by drrect sequencing of Isolated storage bodres. compared wrth the sequences of saposms A 
and D. An astertsk indicates a glycosylatron site. an X mdtcates an umdentrfied amino acid. and a dash Indicates a cysteme or a glycosylated 
asparagme which did not produce a srgnal. 
parison with the known sequences of the saposins [l 11. 
One was found to be identical with the N-terminal se- 
quence of saposin A, and the other to saposin D, which 
is truncated by two amino acids from the sequence de- 
duced from the cDNA (Fig. 3). Cysteine residues, as 
well as the glycosylated asparagine residue, did not pro- 
duce signals in the sequence analysis. 
The protein components of the purified brain storage 
cytosomes were further analyzed on both Laemmli and 
Schagger gels using Coomassie blue and double silver 
staining methods. The results were essentially the same 
in all four patients and in all systems, showing one 
major and several minor protein bands (Fig. 3). The 
major band had an apparent molecular weight of 14 
kDa. N-Terminal sequence analysis showed the pres- 
ence of both saposin A and saposin D in the same band. 
1 2 3 
94 kR - 
67 kD - 
43 kD - 
30 kD - 
20 kD- 
14 kD- 
I . 
J 
Frg. 3. Storage bodies Isolated from two INCL patrents analyzed on 
SDS-PAGE: patrent 1 (lane 1). patrent 2 (lanes 2 and 3). Lanes 1 and 
2 were stamed wrth Coomassie brrlltant blue R, and lane 3 was stained 
wtth the double srlver stain The arrow indrcates the major band 
contaming saposms A and D. as shown by N-termmal sequence anal- 
ysis. The bar indicates protems showmg rmmunoreacttvrty agamst 
GFAP antrserum m Western blottmg. 
Although saposins A and D differ by 3 kDa in molecu- 
lar weight [ 141, they are known to overlap in gels, being 
separable only by high-pressure liquid chromatography 
using a two column system [I 11. 
Minor bands from 20 to 35 kDa in molecular weight 
were also subjected to N-terminal sequence analysis. 
The bands contained both saposin A and saposin D in 
varying proportions in the different bands, and may 
represent aggregated saposins. 
A group of higher molecular weight proteins (35-50 
kDa) were shown to be of glial origin. N-Terminal se- 
quence analysis of a 37 kDa protein showed identity 
with glial fibrillary acidic protein (GFAP). However, 
the N-terminus of this 37 kDa protein was found inside 
GFAP. which, together with the fact that the molecular 
weight of GFAP is approximately 50 kDa [26], suggests 
that GFAP had been partially degraded in the samples. 
Furthermore, this 37 kDa band and several others of 
higher molecular weight (indicated by a bar in Fig. 3) 
reacted with a commercial GFAP-antibody in Western 
blotting. However. the GFAP fragment does not seem 
to be an integral storage body component. Highly ele- 
vated amounts of GFAP in INCL brain has been re- 
ported before [27], and may have caused the contamina- 
tion of storage bodies with a small amount of this pro- 
tein. 
The absence of mitochondrial ATP synthase subunit 
c in the INCL storage material was confirmed by West- 
ern analysis using subunit c antiserum (Fig. 4). Storage 
bodies purified from liver of sheep affected with NCL, 
and storage bodies purified from brain tissue of a JNCL 
patient, were used as positive controls, giving two sig- 
nals corresponding to monomeric and oligomeric forms 
of subunit c (3.5 and 14.8 kDa in apparent molecular 
weight). Storage bodies purified from brain tissue of 
TNCL patients did not show reactivity against subunit 
c antiserum. 
4. DISCUSSION 
The basic biochemical defect remains unknown in all 
forms of NCL, despite a wide variety of hypotheses that 
have been advanced. These include abnormal peroxida- 
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Fig. 4. Western blot using anttserum raised against subunit c of mito- 
chondrtal ATP synthase. Storage bodies isolated from liver of sheep 
affected with NCL (lane l), brain of INCL patient (lane 2). and brain 
of JNCL pattent (lane 3). The two immunoreacttve bands in lanes 1 
and 3 correspond to monomeric and ohgomertc forms of subumt c. 
respecttvely. Note the lack of tmmunoreacttvny of the INCL storage 
bodies. 
tion of lipids [28,29], deficiency of a peroxidase [30], and 
disturbances in the metabolism of fatty acids [31,32], 
iron [33], retinoic acid, dolichols [34,35]. and dolichol- 
linked oligosaccharides [36,37]. Further suggestions in- 
clude a defective thiol endoprotease causing faulty recy- 
cling of lysosomal membranes [38], inhibition of cathep- 
sin B activity by accumulating abnormal peroxides [39], 
a defect in very low density lipoprotein synthesis [40], 
and abnormal methionine S-methylation [41]. None of 
these have been substantiated. 
Recent studies of ovine NCL have shown that the 
storage cytosomes largely consist of protein with one 
major component, subunit c of mitochondrial ATP syn- 
thase [6] with a normal amino acid sequence [21]. Accu- 
mulation of subunit c of mitochondrial ATP synthase 
has also been found in the bovine and certain canine 
forms of NCL, as well as in the human late infantile 
neuronal ceroid-lipofuscinosis (LINCL) and JNCL [7]. 
The primary defects causing these accumulations of 
subunit c are still unknown, but may involve a specific 
degradation pathway for subunit c [7]. 
Our results confirm the earlier observations [7] that 
subunit c is not enriched in the INCL storage bodies. 
The present study also revealed a high protein content 
(43% of dry weight) in storage bodies derived from 
INCL brain, and indicate that saposins A and D consti- 
tute a major portion of the accumulated protein. The 
electrophoretic behaviour of these molecules suggest 
that the complete molecules. or at least substantial por- 
tions of them, are stored. N-Terminal truncation of the 
cDNA-deduced sequence of saposin D is normal and is 
not specific for INCL [42]. 
Recent discoveries of mutations in the prosaposin 
gene have demonstrated the essential role of saposins in 
sphingolipid hydrolysis in human tissues [4345]. How- 
ever, primary disturbances of saposin metabolism have 
not been reported to be associated with storage of 
saposins [43]. It is also of interest in this context to note 
that no accumulation of saposins was observed in 
LINCL [15] when entire brain tissue was analyzed. In 
contrast, an up to 80-fold accumulation of saposins A, 
B, C. and D has been found in spleen and/or liver of 
patients with Gaucher disease, type I Niemann-Pick 
disease, and fucosidosis, as well as in brain of patients 
with TayySachs and infantile Sandhoff diseases 
[l 1.15.161. These are all primary disturbances of spin- 
golipid metabolism with established enzyme defects, 
and consequently the accumulation of saposins seems 
to be a secondary feature. 
Two alternative hypotheses have been advanced to 
explain the accumulation of saposins in the spingolipid 
storage diseases [14]. Firstly, synthesis of saposins may 
be stimulated by the accumulation of a defective target 
hydrolase or lipid as a compensatory mechanism. Sec- 
ondly, saposins may be co-deposited with the accumu- 
lating sphingolipids. Available experimental data 
strongly favor the latter hypothesis. Parallel accumula- 
tion of ganglioside GM, and saposin A has been ob- 
served in Tay-Sachs and Sandhoff diseases, glucocere- 
broside and saposins A and D in Gaucher disease, and 
fucoglycolipid and saposins A and D in fucosidosis [ 151. 
Furthermore, loading of sulfatides into cultured fibrob- 
lasts from a metachromatic leucodystrophy patient has 
been shown to result in simultaneous lysosomal accu- 
mulation of sulfatides and saposin B [46], and the 
amount of saposin C has been reported to increase in 
mouse tissues after injection of glucocerebroside [47]. 
Our present study shows the accumulation of sapos- 
ins A and D, together with lipids, in the storage cy- 
tosomes from brains of INCL patients. The different 
chromosomal localizations of the INCL gene (chromo- 
some 1) and prosaposin gene (chromosome lo), indicate 
that the accumulation of saposins in INCL is likely to 
be a secondary phenomenon. However, the protein-to- 
lipid ratio (>l) in the storage material of INCL patients 
is much higher than that observed in, for example, Tay- 
Sachs disease, where the isolated cytoplasmic membra- 
nous bodies contain only about 10% protein on a weight 
basis [48]. and the actual quantity of saposin A is lower 
than GM, ganglioside by an order of magnitude [15]. 
Additional studies will have to be carried out to fully 
characterize the stored saposins and the mechanism of 
saposin accumulation in INCL, issues likely to be im- 
portant for the understanding of the pathogenesis of 
this disease. 
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